Billionaire Profile
Tse Ping & family
Global Rank
#367

Image: Public domain | via Wikimedia Commons

Tse Ping & family

CEO, Sino Biopharmaceutical
CN
Real-Time Net Worth
$8.9B
As of December 2025
Age
73
Source
Pharmaceuticals
Industry
healthcare
Citizenship
CN

Biography

Tse Ping, a prominent figure in the pharmaceutical industry, is known for his leadership and investment acumen. He is a member of the Dhanin family, a well-known family in Asia. His career began after diverging from his family's agricultural business, choosing to focus on the pharmaceutical industry. This decision led him to establish Sino Biopharmaceutical, where he accumulated over 21 years of experience in investment and management. Under his guidance, the company became a key player in the market for hepatitis drugs and therapeutic microspheres. Tse's achievements have been recognized with awards, including the 'World Outstanding Chinese' award in 2008 and an honorary doctorate. As of December 5, 2025, Tse Ping's net worth is estimated at $8.9 billion, primarily from his investments in pharmaceuticals.

Wealth Over Time

In-Depth Profile

Early Life

Tse Ping was born into the Dhanin family, a prominent Asian clan. During the 1950s, most of his family immigrated to Thailand, but Tse remained in China. During the Mao-era Cultural Revolution, he was sent to the countryside from Shantou, missing out on college opportunities. In the 1970s, he applied for immigration papers with the help of his family headquarters in Hong Kong and eventually moved there.

Rise to Success

Tse Ping chose to diverge from his family's agricultural business and entered the pharmaceutical industry, recognizing its counter-cyclical nature. Accumulating over 21 years of pharmaceutical-related investment and management experience, he led Sino Biopharmaceutical to prominence. Under his leadership, Sino Pharmaceuticals became a formidable competitor in hepatitis drugs and therapeutic microsphere targeted medicine markets. Foreign interest in his progress was evident, with Goldman Sachs acquiring a stake in Sino Biopharmaceuticals.

Key Business Strategies

Tse Ping's strategy involved identifying opportunities in the pharmaceutical industry. He focused on acquiring drugmakers and improving their operations. He also recognized the potential of the aging Chinese population as a key market.

Philanthropy

Details about Tse Ping's specific philanthropy are not readily available in the search results.

Career Milestones

2000

Founded Sino Biopharmaceutical

Tse founded Sino Biopharmaceutical with the operations of the remaining businesses.

2005

Forbes Asia Award

Sino Pharmaceuticals won the Forbes Asia 'Best Under $1 billion enterprise within the Asia Pacific Region' award.

2008

'World Outstanding Chinese' Award

Tse Ping received the 'World Outstanding Chinese' award in Hong Kong.

2008

Honorary Doctorate

Received an honorary Doctorate degree from the University of West Alabama, USA.

2015

Stepped Down as Chairman

Stepped down as chairman of Sino Biopharmaceutical and ceded the role to his daughter.

2022

Son Eric Tse became CEO

His son Eric rose to CEO.

Philanthropy & Social Impact

N/A

Not available

Undisclosed

Philanthropic initiatives are not available.

Business Philosophy & Leadership

Notable Quotes

"Not available"

Leadership Principles

Not available

Leadership principles are not available.

Controversies & Challenges

Not available

Not available

Controversies are not available.